These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18060912)

  • 1. Potential ipriflavone and warfarin interaction.
    Anderson DC; Scoggins BP
    Am J Med; 2007 Dec; 120(12):e3. PubMed ID: 18060912
    [No Abstract]   [Full Text] [Related]  

  • 2. Warfarin: a dauntingly interactional medication.
    Straughan JL
    Cardiovasc J Afr; 2007; 18(6):397-8. PubMed ID: 18092119
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug interaction with coumarin anticoagulants.
    Kayser SR
    Prog Cardiovasc Nurs; 1993; 8(1):40-5. PubMed ID: 8372087
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction between gemfibrozil and warfarin: case report and review of the literature.
    Dixon DL; Williams VG
    Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of methimazole on warfarin anticoagulation in a case of Graves' disease.
    Akin F; Yaylali GF; Bastemir M; Yapar B
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):89-91. PubMed ID: 18180622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favourable use of non-boosted fosamprenavir in patients treated with warfarin.
    Honda H; Gatanaga H; Matsumura J; Kamimura M; Goto K; Tsukada K; Honda M; Teruya K; Kikuchi Y; Oka S
    Int J STD AIDS; 2009 Jun; 20(6):441. PubMed ID: 19451340
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulants.
    Peck AW
    Br J Hosp Med; 1977 Jan; 17(1):90. PubMed ID: 843677
    [No Abstract]   [Full Text] [Related]  

  • 8. An evidence-based dentistry challenge: treating patients on warfarin (Coumadin).
    Goodchild JH; Donaldson M
    Dent Implantol Update; 2009 Jan; 20(1):1-8. PubMed ID: 19170364
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of use and the risk of adverse effects associated with complementary and alternative medicine in a cohort of patients receiving warfarin.
    Leung VW; Shalansky SJ; Lo MK; Jadusingh EA
    Ann Pharmacother; 2009 May; 43(5):875-81. PubMed ID: 19401475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin monitoring: consider the three Ds.
    Beier MT
    J Am Med Dir Assoc; 2005; 6(1):76. PubMed ID: 15871876
    [No Abstract]   [Full Text] [Related]  

  • 11. A systematic approach to managing warfarin doses.
    Ebell MH
    Fam Pract Manag; 2005 May; 12(5):77, 79-80, 83. PubMed ID: 15929383
    [No Abstract]   [Full Text] [Related]  

  • 12. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversal of osmolite-warfarin interaction by changing warfarin administration time.
    Petretich DA
    Clin Pharm; 1990 Feb; 9(2):93. PubMed ID: 2106407
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition.
    Dickerson RN; Garmon WM; Kuhl DA; Minard G; Brown RO
    Pharmacotherapy; 2008 Mar; 28(3):308-13. PubMed ID: 18294110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of physical activity on warfarin therapy.
    Shibata Y; Hashimoto H; Kurata C; Ohno R; Kazui T; Takinami M
    Thromb Haemost; 1998 Jul; 80(1):203-4. PubMed ID: 9684814
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between warfarin and tamoxifen: a case report.
    Mishra D; Paudel R; Kishore PV; Palaian S; Bista D; Misra P
    Kathmandu Univ Med J (KUMJ); 2007; 5(1):105-7. PubMed ID: 18603996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ipriflavone.
    Altern Med Rev; 2000 Jun; 5(3):260-3. PubMed ID: 10869105
    [No Abstract]   [Full Text] [Related]  

  • 19. Warfarin: an old drug but still interesting.
    Johnson JA
    Pharmacotherapy; 2008 Sep; 28(9):1081-3. PubMed ID: 18752378
    [No Abstract]   [Full Text] [Related]  

  • 20. Updated review of oral anticoagulants resistance. A case report.
    Alloza JL
    Arch Farmacol Toxicol; 1984 Apr; 10(1):45-56. PubMed ID: 6508369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.